title: Failure to thrive potentially secondary to maternal venlafaxine use.
authors: Sydney, NSW.
authors: Michael Ma
authors: MM
authors: Tran
authors: Sydney, NSW.
authors: Nicholas
authors: N
authors: Fancourt
authors: Sydney, NSW.
authors: Joanne M
authors: JM
authors: Ging
authors: Sydney, NSW.
authors: Esther M
authors: EM
authors: Tantsis
authors: Sydney, NSW.
authors: T Y
authors: TY
authors: Nelson
authors: Sydney, NSW.
authors: Reva
authors: R
authors: Sharma
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D001007:Anxiety / Q000188:drug therapy; D001835:Body Weight; D001942:Breast Feeding; D003863:Depression / Q000188:drug therapy; D005183:Failure to Thrive / Q000209:etiology*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D000069470:Venlafaxine Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000069470:Venlafaxine Hydrochloride